2019-12-02| R&D

Regenerative Medicine provides Answer to Aging: ICare Global Health Biotech’s SRF Technology Aims to Treat Arthritis in the Elderly

by GeneOnline
Share To

The world today comprises an aging society which facing many common diseases that affect the bones, muscles and leads to deteriorated joints. Therefore, one of the major challenges for healthcare in the future is to address these issues by devising new and effective prevention methods and provide a better quality of living for the aging population.

Self Repair Factors (SRF): A New Treatment Option for Arthritis in the Elderly

Autologous platelet-rich plasma (PRP) intra-articular injection, intra-articular hyaluronic acid injection, and gluco proliferative methods are currently some of the prevalent therapies for diseases such as arthritis and muscular joint degeneration. However, they are time-consuming and have other disadvantages including lower blood platelet concentration and slower repair. Recently, ICare Global Health Biotech has launched a new product called the Self Repair Factors concentration and accelerate tissue repair. This product targets patients suffering from joint discomfort, sports injuries (sprains, strains), occupational diseases (tennis elbow, mouse shoulder, office worker shoulder, and neck stiffness and soreness, etc.), recurrent dislocation and knee pain caused by overweight.

Furthermore, this therapy integrates biomedicine, sports medicine, orthopedics, and rehabilitation treatments. After receiving the SRF injections, patients can combine it with other dynamic balance treatments to strengthen their core muscles and spinal support or relax with a deep muscle massage rehabilitation treatment to improve overall muscle and joint coordination. After the injection, the healthcare team will provide relevant suggestions for postoperative care, pay close attention to the postoperative condition, and arrange a time for a return visit to improve the maintenance of the patient’s joints.

If you wish to learn more about the platelet autogrowth factor, SRF, and peripheral blood stem cell storage products and related technologies, you may visit the Healthcare+ Expo Taiwan next week (12/5 ~ 12/8) at booth Q1413 for these two products/services.


© All rights reserved. Collaborate with us:
Related Post
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
Human Longevity Plans to Merge With Blank Check Company to Go Public
Overcoming Aging Related Hearing Loss- A Possibility In The Not So Distant Future
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top